Experts in Pharma & Biotech Compensation Strategy
Over 40 Years Supporting the Life Sciences and Healthcare Sector
What Sets Bedford Apart
In Pharma & Biotech Compensation
Bedford Group brings over four decades of experience advising Life Sciences organisations on executive and board-level compensation. We help design strategies that meet high stakeholder expectations while supporting growth and impact. Our services include benchmarking, incentive plan design, board pay reviews and the publication of trusted annual compensation surveys.

Specialized Expertise in Pharma & Biotech Compensation
With a dedicated practice in Pharmaceuticals, Biotechnology, Medical Devices, and Healthcare Services, Bedford offers deep industry knowledge. Our sector-specific expertise spans drug development, clinical research, diagnostics, and healthcare delivery, ensuring tailored compensation strategies that resonate with top talent and meet industry standards.

Industry-Leading Insights
Bedford is a recognized authority in pharmaceutical and biotechnology compensation, conducting annual industry-wide executive and board compensation surveys to provide essential insights. These compensation reports, combined with our expertise, ensure that you remain competitive and aligned with industry standards, helping to attract and retain top talent.

Tailored Compensation Studies
Every study we deliver is custom-built around your organisation’s structure, growth phase, and leadership goals. We review each named executive role and benchmark against carefully selected peer groups to design tailored, defensible pay strategies that resonate with top talent and satisfy stakeholder expectations.

Global Reach, Local Knowledge
Access world-class executive and board compensation research through Bedford’s robust global salary data repository. Our biotech and healthcare clients benefit from international benchmarking tools and a connected global network, ensuring their pay strategies align with global standards while supporting local talent retention and leadership planning.
#1
performing office among 60 global locations in TRANSEARCH
1000+
compensation benchmarking studies delivered
40+
years of industry-specific compensation research
60
offices in 40+ countries
Comprehensive Solutions

Compensation Benchmarking
We specialize in peer-group executive and director compensation benchmarking, utilizing both publicly available and proprietary salary data. Our peer groups are meticulously selected based on company size, market cap and asset value, geography, growth phase, and other factors.

Executive & Board Compensation Strategy
For four decades, we have provided independent advisory to public and private companies on all aspects of executive and board compensation strategy including salary structure and incentive pay, long term incentives and share plans, termination and change in control provisions, and employee share purchase plans.

Compensation Governance
We assist with all matters relating to compensation governance to ensure compliance with legislative and shareholder requirements and industry best practices. Our insights help build credibility with boards, investors, and advisory firms.

Compensation Policy
We help align your compensation policy with your organizational goals and strategic priorities. We help define the roles and responsibilities of various stakeholders (e.g., the Compensation Committee, the Board of Directors, institutional investors, etc.) within the compensation policy design and review process.
Biotech Compensation Reports
Stay Competitive with Trusted Industry Data
Our annual compensation reports provide practical insight into evolving pay practices for organizations in the pharmaceutical and biotechnology sectors, ensuring your pay strategy is both competitive and defensible.
Download the Latest Reports for Biotech Compensation Trends.
Meet Our Experts
Specialists in Life Sciences & Healthcare Compensation Strategy



Darren Raycroft
Ready to Build a Smarter Pay Strategy?
Let’s Talk Life Sciences Compensation
Partner with Bedford to align your executive and board compensation with performance, strategy, and shareholder expectations.